- Home
- WKHS vs COEP Comparison
WKHS vs COEP Comparison
Compare WKHS & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKHS
- COEP
- Stock Information
- Founded
- WKHS 2007
- COEP 2017
- Country
- WKHS United States
- COEP United States
- Employees
- WKHS N/A
- COEP N/A
- Industry
- WKHS Auto Manufacturing
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WKHS Consumer Discretionary
- COEP Health Care
- Exchange
- WKHS Nasdaq
- COEP Nasdaq
- Market Cap
- WKHS 20.0M
- COEP 62.4M
- IPO Year
- WKHS N/A
- COEP N/A
- Fundamental
- Price
- WKHS $1.12
- COEP $12.75
- Analyst Decision
- WKHS Hold
- COEP
- Analyst Count
- WKHS 2
- COEP 0
- Target Price
- WKHS $8.68
- COEP N/A
- AVG Volume (30 Days)
- WKHS 769.1K
- COEP 38.9K
- Earning Date
- WKHS 08-15-2025
- COEP 11-12-2025
- Dividend Yield
- WKHS N/A
- COEP N/A
- EPS Growth
- WKHS N/A
- COEP N/A
- EPS
- WKHS N/A
- COEP N/A
- Revenue
- WKHS $10,745,014.00
- COEP $263,555.00
- Revenue This Year
- WKHS $92.70
- COEP N/A
- Revenue Next Year
- WKHS $34.00
- COEP N/A
- P/E Ratio
- WKHS N/A
- COEP N/A
- Revenue Growth
- WKHS 11.73
- COEP N/A
- 52 Week Low
- WKHS $0.81
- COEP $2.31
- 52 Week High
- WKHS $24.25
- COEP $14.70
- Technical
- Relative Strength Index (RSI)
- WKHS 33.60
- COEP 52.28
- Support Level
- WKHS $1.13
- COEP $12.09
- Resistance Level
- WKHS $1.34
- COEP $13.25
- Average True Range (ATR)
- WKHS 0.07
- COEP 0.73
- MACD
- WKHS 0.00
- COEP -0.12
- Stochastic Oscillator
- WKHS 14.14
- COEP 51.26
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.